Mortalidad entre los pacientes en tratamiento con metadona e infectados con el virus de la inmunodeficiencia humana y/o hepatitis C
DOI:
https://doi.org/10.20882/adicciones.1007Palabras clave:
Heroina, Metadona, Tasa bruta mortalidad, Virus hepatitis c, Virus inmunodeficiencia humanaResumen
Carta al editor.Citas
Elizalde, I., Iñarrairaegui, M., Rodríguez, C. y Zozaya, J. M. (2004). Treatment of chronic hepatitis C virus infection. Anales del Sistema Sanitario de Navarra, 27, 81-90.
González-Álvarez, S., Madoz-Gúrpide, A., Parro-Torres, C., Hernández-Huerta, D. y Ochoa Mangado, E. (2017). Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV+ patients. Adicciones. Avance de publicación on-line. doi:10.20882/adicciones.916.
Hser, Y. I., Hoffman, V., Grella, C. E. y Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503–508. doi:10.1001/archpsyc.58.5.503.
Kleber, H. D. (2008). Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. Journal of the American Medical Association, 300, 2303–2305. doi:10.1001/jama.2008.648.
Muga, R., Roca, J., Egea, J. M., Tor, J., Sirera, G. y Rey-Joly, C. (2000). Mortality of HIV-positive and HIV- negative heroin abusers as a function of duration of injecting drug use. The Journal of Acquired Immune Deficiency Syndromes, 23, 332–338.
Pedrero-Pérez, E. J. y MethaQoL, G. (2017). Methadone dosage and its relationship to quality of life, satisfaction, psychopathology, cognitive performance and additional consumption of non-prescribed drugs. Adicciones,29, 37-54.doi:10.20882/adicciones.831.
Roncero, C., Vega, P., Martinez-Raga, J. y Torrens, M. (2017). Chronic Hepatitis C and people with a history of injecting drugs in Spain: population assessment, challenges for effective treatment. Adicciones, 29, 71-73. doi:10.20882/adicciones.908.
Santos, I. y Sanz, J. (2004). Tratamiento con interferón y ribavirina de la hepatitis crónica por virus C en pacientes con infección por VIH. Anales de Medicina Interna, 21, 369-372.
Zanis, D.A. y Woody, G. E. (1998). One year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence, 52, 257-260. doi:10.1016/S0376-8716(98)00097-0.
